Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Werner-Wasik

Showing results (131-140 of 159) with videos related to

Pageof 16
Sort By:
Frontiers in Oncology|May 16, 2022
Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed GlioblastomaRyan Miller, Andrew Song, Ayesha Ali, et al.
Journal of Neuro-Oncology|April 28, 2011
Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ≤ 6 brain metastases: a multi-institutional phase II trialDerek R McHaffie, Pierre Chabot, Anne Dagnault, et al.
Neurosurgery|September 18, 2002
Fractionated stereotactic radiotherapy for the treatment of optic nerve sheath meningiomas: preliminary observations of 33 optic nerves in 30 patients with historical comparison to observation with or without prior surgeryDavid W Andrews, Rod Faroozan, Benson P Yang, et al.
Journal of Neuro-Oncology|September 6, 2018
Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?Joshua D Palmer, Deepak Bhamidipati, Andrew Song, et al.
Frontiers in Oncology|March 29, 2021
Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung CancerCathryn B Crockett, Pamela Samson, Robert Chuter, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2013
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320Paul W Sperduto, Meihua Wang, H Ian Robins, et al.
Journal of Neurosurgery|October 7, 2017
Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539Leland Rogers, Peixin Zhang, Michael A Vogelbaum, et al.
Oncotarget|April 8, 2017
Genetic landscape of extreme responders with anaplastic oligodendrogliomaMatthias Holdhoff, Gregory J Cairncross, Thomas M Kollmeyer, et al.
International Journal of Radiation Oncology, Biology, Physics|October 19, 2010
Reirradiation human spinal cord tolerance for stereotactic body radiotherapyArjun Sahgal, Lijun Ma, Vivian Weinberg, et al.
International Journal of Radiation Oncology, Biology, Physics|November 6, 2017
Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525Wenyin Shi, Molly Scannell Bryan, Mark R Gilbert, et al.
Pageof 16

Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
Frontiers in Oncology|May 16, 2022
Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed GlioblastomaRyan Miller, Andrew Song, Ayesha Ali, et al.
Journal of Neuro-Oncology|April 28, 2011
Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ≤ 6 brain metastases: a multi-institutional phase II trialDerek R McHaffie, Pierre Chabot, Anne Dagnault, et al.
Neurosurgery|September 18, 2002
Fractionated stereotactic radiotherapy for the treatment of optic nerve sheath meningiomas: preliminary observations of 33 optic nerves in 30 patients with historical comparison to observation with or without prior surgeryDavid W Andrews, Rod Faroozan, Benson P Yang, et al.
Journal of Neuro-Oncology|September 6, 2018
Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?Joshua D Palmer, Deepak Bhamidipati, Andrew Song, et al.
Frontiers in Oncology|March 29, 2021
Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung CancerCathryn B Crockett, Pamela Samson, Robert Chuter, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2013
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320Paul W Sperduto, Meihua Wang, H Ian Robins, et al.
Journal of Neurosurgery|October 7, 2017
Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539Leland Rogers, Peixin Zhang, Michael A Vogelbaum, et al.
Oncotarget|April 8, 2017
Genetic landscape of extreme responders with anaplastic oligodendrogliomaMatthias Holdhoff, Gregory J Cairncross, Thomas M Kollmeyer, et al.
International Journal of Radiation Oncology, Biology, Physics|October 19, 2010
Reirradiation human spinal cord tolerance for stereotactic body radiotherapyArjun Sahgal, Lijun Ma, Vivian Weinberg, et al.
International Journal of Radiation Oncology, Biology, Physics|November 6, 2017
Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525Wenyin Shi, Molly Scannell Bryan, Mark R Gilbert, et al.
Pageof 16